Meritage Group’s CVS Health CVS Stock Holding History

Meritage Group’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-43,916	Closed	-$3.46M	–	37
2016 Q4	$3.46M	Buy	+43,916	New	+$3.55M	0.09%	28

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Meritage Group's CVS Position: Q1 2017 in Review

Meritage Group sold out of CVS Health (CVS) in Q1 2017, closing a stake of 43,916 shares — an estimated $3.46M sold.

Meritage Group first reported a position in CVS in Q4 2016 and held it in 1 quarter. The position peaked at $3.46M in Q4 2016. 1,575 funds tracked by Wall St. Rank hold CVS as of Q1 2017.

Meritage Group reported no remaining CVS Health position as of Q1 2017 after selling out during the quarter.
Meritage Group sold 43,916 CVS Health shares in Q1 2017, an estimated $3.46M.
Meritage Group first reported a position in CVS Health in Q4 2016 and held it in 1 quarter.
Meritage Group's CVS Health position peaked at $3.46M in Q4 2016.
1,575 funds tracked by Wall St. Rank held CVS Health as of Q1 2017.

Based on Meritage Group's 13F filing for Q1 2017, filed 12 May 2017.